SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001068144-05-000120
Filing Date
2005-02-17
Accepted
2005-02-16 17:58:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 pharma.txt SC 13G/A 6796
  Complete submission text file 0001068144-05-000120.txt   8306
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48083 | Film No.: 05621926
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 605 THIRD AVE NEW YORK NY 10158
Business Address 605 THIRD AVE NEW YORK NY 10158 2124769870
NEUBERGER BERMAN INC (Filed by) CIK: 0001068144 (see all company filings)

IRS No.: 061523639 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice